z-logo
Premium
The peripheral cannabinoid receptor knockout mice: an update
Author(s) -
Buckley N E
Publication year - 2008
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0707527
Subject(s) - cannabinoid receptor , knockout mouse , cannabinoid , cannabinoid receptor agonists , receptor , inflammation , immune system , apoptosis , pharmacology , synthetic cannabinoids , immunology , biology , medicine , agonist , biochemistry
This review gives an overview of the CB 2 receptor (CB 2 R) knockout (CB 2 R −/− ) mice phenotype and the work that has been carried out using this mutant mouse. Using the CB 2 R −/− mice, investigators have discovered the involvement of CB 2 R on immune cell function and development, infection, embryonic development, bone loss, liver disorders, pain, autoimmune inflammation, allergic dermatitis, atherosclerosis, apoptosis and chemotaxis. Using the CB 2 R −/− mice, investigators have also found that this receptor is not involved in cannabinoid‐induced hypotension. In addition, the CB 2 R −/− mice have been used to determine specific tissue CB 2 R expression. The specificity of synthetic cannabinoid agonists, antagonists and anti‐CB 2 R antibodies has been screened using tissues from CB 2 R −/− mice. Thus, the use of this mouse model has greatly helped reveal the diverse events involving the CB 2 R, and has aided in drug and antibody screening. British Journal of Pharmacology (2008) 153 , 309–318; doi: 10.1038/sj.bjp.0707527 ; published online 29 October 2007

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom